François Gros-Louis
Chercheur universitaire
Axe Médecine régénératrice
Médecine régénérative
Biologie des systèmes
Neurodégénérescence
Neurogénétique
Neuroscience cellulaire
Neuroscience moléculaire
Maladies rares
Publications
View all-
article Bienjonetti I, Roy V, Beaudet MJ, Louit A, Martineau L, Berthod F, Dupré N, Gros-Louis F
Rapid Generation of Functional Oligodendrocytes From Human Induced Pluripotent Stem Cells Through Small Molecule Guided Differentiation
J Neurosci Res 104 (9), 2026.
-
article Villa C, Martineau L, Bellenfant S, Gros-Louis F, Farini A, Torrente Y
Generation of two LGMDR4 patients derived induced pluripotent stem cell line carrying the SGCB frameshift mutation (p.Gly129_Arg130insGlnTer)
Stem Cell Res 94 2026.
-
article Paquet A, Touzel-Deschênes L, Roy V, Saikali S, Dupré N, Gros-Louis F
Proteomic Analysis of Corpora Amylacea Extracted From Post-mortem Brain of MAiD-end-of-life Sporadic ALS Patients
Brain Behav 16 (5), 2026.
Projects
- A cGMP facility for personalized tissue engineering, from 2024-12-01 to 2027-12-31
- Chaire de recherche du Canada en génie tissulaire et modélisation 3D des maladies du cerveau, from 2023-05-01 to 2030-04-30
- Organogenèse de muqueuse nasale autologue pour la reconstruction endoscopique endonasale en chirurgie de la base du crâne, from 2023-10-01 to 2028-09-30
- Depicting disease heterogeneity in neurofibromatosis type 1 and the role of dermal fibroblasts in the establishment of microenvironment favouring NF1-associated skin tumor formation using personalized tissue-engineered 3D models, from 2023-10-01 to 2028-09-30
- Étudier le rôle de la matrice extracellulaire dans la Sclérose Latérale Amyotrophique à l'aide de modèles in vitro 3D personnalisés produits par génie tissulaire, from 2025-10-01 to 2030-09-30
- Redefining ARSACS: Exploring TDP-43 Proteinopathy as a Novel Pathogenic Mechanism, from 2025-09-01 to 2027-08-31
- Tissue of Origin Matters: Impact of Somatic Cell Source on iPSC-Derived Neuronal Models, from 2026-04-01 to 2031-03-31
- Connecting the NF1-organoid model to biotechs requirement for drug assay, from 2024-10-10 to 2025-09-30
- Développement d'une thérapie par oligonucléotide antisens contre la DMOP utilisant la modélisation tissulaire 3D avancée, from 2025-01-01 to 2025-12-31
- Generation of patient-derived Isogenic iPSC Lines of ARSACS Patients: A Critical Resource for Therapeutic Development, from 2024-03-01 to 2026-02-28